Aprepitant and Otitis - a phase IV clinical study of FDA data

Summary:

Otitis is reported as a side effect among people who take Aprepitant (aprepitant), especially for people who are female, 40-49 old, also take Sulfasalazine, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Otitis when taking Aprepitant. It is created by eHealthMe based on reports of 6,989 people who have side effects when taking Aprepitant from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Otitis?

Otitis (ear infection) is found to be associated with 1,416 drugs and 1,832 conditions by eHealthMe. Check the latest studies of Otitis.

On Jul, 22, 2026

6,989 people reported to have side effects when taking Aprepitant.
Among them, 14 people (0.2%) have Otitis.

Among these 14 people:

What is the gender of people who have Otitis when taking Aprepitant? *

female: 100 %
male: 0.0 %

What is the age of people who have Otitis when taking Aprepitant? *

What are other drugs people take besides Aprepitant? *

Acetaminophen: 14 people, 100.00%
Prednisone: 14 people, 100.00%
Leflunomide: 14 people, 100.00%
Folic Acid: 14 people, 100.00%
Diclofenac Sodium: 14 people, 100.00%
Diclofenac Potassium: 14 people, 100.00%
Methotrexate: 14 people, 100.00%
Desoximetasone: 14 people, 100.00%
Alendronic Acid: 14 people, 100.00%
Sulfasalazine: 14 people, 100.00%

What are other side effects people have besides Otitis? *

Foot Deformity (functional disability of foot): 14 people, 100.00%
Lupus-Like Syndrome (a disease symptom matches with lupus an immune disease): 14 people, 100.00%
Laryngitis (inflammation of the larynx): 14 people, 100.00%
Joint Dislocation (a joint position is changed from normal position): 14 people, 100.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 14 people, 100.00%
High Blood Cholesterol: 14 people, 100.00%
Exostosis (formation of new bone on the surface of a bone): 14 people, 100.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 13 people, 92.86%
Head Injury: 8 people, 57.14%
Joint Pain: 8 people, 57.14%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 100.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 78.57%
Psoriasis (immune-mediated disease that affects the skin): 10 people, 71.43%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 9 people, 64.29%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 7 people, 50.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 7 people, 50.00%
Joint Pain: 4 people, 28.57%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 21.43%
Abdominal Discomfort: 2 people, 14.29%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and have Otitis?

- Check whether Otitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aprepitant:

Aprepitant (6,992 reports)

Otitis treatments and more:

Otitis (36,446 reports)

Browse all side effects of Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Otitis:

Otitis (1,416 drugs)

Browse all the conditions that are associated with Otitis:

Otitis (1,832 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant (the active ingredients of Aprepitant) and Aprepitant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.